| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |